PJSC “Pharmaceutical firm ”Darnitsa” (Kiev) has suspended production due to overcrowding of warehouses, which arose due to a conflict with pharmacy chains.
As the Economic Pravda newspaper reported, the company’s warehouses are “filled to overflowing due to the unwillingness of the largest pharmacy chains to sell the company’s products”.
The Interfax-Ukraine agency contacted the company to comment on the situation, but has not yet received a response.
Darnitsa Pharmaceutical Company is the leader of the Ukrainian pharmaceutical market in physical terms. The company has been on the market for over 90 years and produces 180 brands of medicines in 15 different forms. The strategic directions of portfolio development are cardiology, neurology, pain management.
The ultimate beneficiary of the company is Gleb Zagoriy.
